iShares Global Healthcare ETF
IXJ.AX
Australian Securities Exchange- -
AUD
- -
- -
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Financial Services
- Industry
- Asset Management - Global
- Address
- Level 18, 120 Collins Street Melbourne Australia 3000
- IPO Date
- Mar 10, 2009
- Website
- blackrock.com
- Similar Companies
- Business
- iShares Global Healthcare ETF (AU) (IXJ.AX) is an exchange-traded fund that seeks to track the investment results of an index composed of global equities in the healthcare sector. The fund provides exposure to companies engaged in pharmaceuticals, biotechnology, healthcare equipment, life sciences tools and services, and healthcare providers and facilities; it includes major holdings such as Eli Lilly & Co., UnitedHealth Group Inc., and AbbVie Inc., selected based on market capitalization and liquidity criteria from the S&P Global 1200 Healthcare Index. Managed by BlackRock Fund Advisors as part of the iShares family, the ETF was launched in 2001 with inception for the Australian listing in 2007 and is domiciled in Australia with primary operations through the ASX exchange. The ETF targets institutional and retail investors seeking diversified healthcare sector exposure across developed markets including North America, Europe, and Asia-Pacific; it features low expense ratios, daily liquidity, and dividend reinvestment options typical of iShares UCITS ETFs. Geographically, it operates globally with heaviest weighting in the United States (over 70%), followed by Switzerland, Denmark, and other regions, serving a broad customer base of portfolio managers, financial advisors, and individual investors focused on defensive growth sectors. In recent developments, the fund benefited from BlackRock's strategic enhancements in 2024-2025, including expanded ESG integration across iShares ETFs and a major partnership with Microsoft for AI-driven portfolio analytics announced in late 2024; additionally, it saw asset inflows exceeding $500 million amid healthcare sector rallies post-2024 U.S. elections, alongside a minor index rebalancing in Q3 2025 to incorporate emerging biotech innovators. No significant name changes or reorganizations occurred, but BlackRock's acquisition of Global X ETFs in 2024 bolstered iShares' thematic offerings complementary to IXJ.AX. These updates position the ETF for sustained growth in an aging global population demographic.